Stocks and Investing
Stocks and Investing
Mon, August 8, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, August 5, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
John Kreger Downgraded (XRAY) to Sell on, Aug 5th, 2022
John Kreger of William Blair, Downgraded "DENTSPLY SIRONA Inc." (XRAY) to Sell on, Aug 5th, 2022.
John has made no other calls on XRAY in the last 4 months.
There are 7 other peers that have a rating on XRAY. Out of the 7 peers that are also analyzing XRAY, 5 agree with John's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Nathan Rich of "Goldman Sachs" Maintained at Hold with Decreased Target to $41 on, Thursday, July 21st, 2022
- Yi Chen of "HC Wainwright & Co." Maintained at Hold with Decreased Target to $48 on, Friday, April 22nd, 2022
- Michael Cherny of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $49 on, Wednesday, April 20th, 2022
- Jason Bednar of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $46 on, Wednesday, April 20th, 2022
- Jeffrey Johnson of "Baird" Downgraded from Buy to Hold and Held Target at $48 on, Tuesday, April 19th, 2022
These are the ratings of the 2 analyists that currently disagree with John
- Erin Wright of "Morgan Stanley" Maintained at Buy with Decreased Target to $44 on, Wednesday, July 20th, 2022
- Kevin Caliendo of "UBS" Upgraded from Hold to Strong Buy and Decreased Target to $47 on, Thursday, June 2nd, 2022
Contributing Sources